{"count": 4, "results": [{"_id": "36254086", "pmid": 36254086, "pmcid": "PMC9575712", "title": "Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients", "journal": "Medicine (Baltimore)", "authors": ["Chen M", "Ma F", "Su B", "Wang C", "Zheng Q", "Zhang Y", "Li M", "Liu S", "Zhang S", "Yuan L"], "date": "2022-10-14T00:00:00Z", "doi": "10.1097/MD.0000000000031107", "meta_date_publication": "2022 Oct 14", "meta_volume": "101", "meta_issue": "41", "meta_pages": "e31107", "score": 50288.855, "text_hl": "The present study suggested that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ application reduced the incidence of @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@ISR@@@. ", "citations": {"NLM": "Chen M, Ma F, Su B, Wang C, Zheng Q, Zhang Y, Li M, Liu S, Zhang S, Yuan L. Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients Medicine (Baltimore). 2022 Oct 14;101(41):e31107. PMID: 36254086", "BibTeX": "@article{36254086, title={Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients}, author={Chen M and Ma F and Su B and Wang C and Zheng Q and Zhang Y and Li M and Liu S and Zhang S and Yuan L}, journal={Medicine (Baltimore)}, volume={101}, number={41}, pages={e31107}}"}}, {"_id": "19635170", "pmid": 19635170, "pmcid": "PMC2727510", "title": "The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus", "journal": "Cardiovasc Diabetol", "authors": ["Lexis CP", "Rahel BM", "Meeder JG", "Zijlstra F", "van der Horst IC"], "date": "2009-07-28T00:00:00Z", "doi": "10.1186/1475-2840-8-41", "meta_date_publication": "2009 Jul 28", "meta_volume": "8", "meta_issue": "", "meta_pages": "41", "score": 50072.77, "text_hl": "Current data of especially @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@ indicate beneficial results as compared to @GENE_INS @GENE_3630 @@@insulin@@@ and @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ on @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@. ", "citations": {"NLM": "Lexis CP, Rahel BM, Meeder JG, Zijlstra F, van der Horst IC. The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus Cardiovasc Diabetol. 2009 Jul 28;8():41. PMID: 19635170", "BibTeX": "@article{19635170, title={The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus}, author={Lexis CP and Rahel BM and Meeder JG and Zijlstra F and van der Horst IC}, journal={Cardiovasc Diabetol}, volume={8}, pages={41}}"}}, {"_id": "19514538", "pmid": 19514538, "title": "[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches].", "journal": "Rev Med Liege", "authors": ["Nyssen A", "Legrand V", "Scheen AJ"], "date": "2009-04-01T00:00:00Z", "meta_date_publication": "2009 Apr", "meta_volume": "64", "meta_issue": "4", "meta_pages": "192-8", "score": 50054.484, "text_hl": "[Incidence of @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@ and cardiac events after coronary angioplasty in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@: reduction by systemic pharmacological approaches].", "citations": {"NLM": "Nyssen A, Legrand V, Scheen AJ. [Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches]. Rev Med Liege. 2009 Apr;64(4):192-8. PMID: 19514538", "BibTeX": "@article{19514538, title={[Incidence of restenosis and cardiac events after coronary angioplasty in diabetic patients: reduction by systemic pharmacological approaches].}, author={Nyssen A and Legrand V and Scheen AJ}, journal={Rev Med Liege}, volume={64}, number={4}, pages={192-8}}"}}, {"_id": "26440772", "pmid": 26440772, "title": "Optimal blood pressure in patients with peripheral artery disease following endovascular therapy.", "journal": "Blood Press", "authors": ["Sasaki H", "Ura N", "Hata S", "Moniwa N", "Hasegawa K", "Takizawa H", "Tanaka S"], "date": "2016-01-01T00:00:00Z", "doi": "10.3109/08037051.2016.1093717", "meta_date_publication": "2016", "meta_volume": "25", "meta_issue": "1", "meta_pages": "36-43", "score": 50052.855, "text_hl": "In the @<m>DISEASE_Coronary_Restenosis</m> @DISEASE_MESH:D023903 @@@restenosis@@@ group, there was a significantly higher percentage of @SPECIES_9606 @@@patients@@@ taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (p < 0.01) than in the other group. ", "citations": {"NLM": "Sasaki H, Ura N, Hata S, Moniwa N, Hasegawa K, Takizawa H, Tanaka S. Optimal blood pressure in patients with peripheral artery disease following endovascular therapy. Blood Press. 2016;25(1):36-43. PMID: 26440772", "BibTeX": "@article{26440772, title={Optimal blood pressure in patients with peripheral artery disease following endovascular therapy.}, author={Sasaki H and Ura N and Hata S and Moniwa N and Hasegawa K and Takizawa H and Tanaka S}, journal={Blood Press}, volume={25}, number={1}, pages={36-43}}"}}]}